CTIS2023-504869-23-00进行中（未招募）1 期
A Phase 3b/4 Randomized, Blinded, Treat-to-Target and Dose-Flexibility Study of Upadacitinib in Adult Subjects with Moderate to Severe Atopic Dermatitis (Flex-Up) - M22-000
适应症
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 438
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 64（—）
- 性别
- All
入选标准
- •Male or female subjects =18 and < 65 years of age at the Screening Visit, Chronic AD with onset of symptoms at least 3 years prior to Baseline and subject meets Hanifin and Rajka criteria, Candidate for systemic treatment
排除标准
- •Prior exposure to any JAK inhibitor, Unable or unwilling to discontinue current AD treatments prior to the study, Requirement of prohibited medications during the study treatment, Female subject who is pregnant, breastfeeding, or considering pregnancy during the study
研究者
相似试验
进行中（未招募）
1 期
This is a study to evaluate dose-flexibility of Upadacitinib in Adult Subjectswith Moderate to Severe Atopic DermatitisModerate to Severe Atopic DermatitisMedDRA version: 20.0Level: PTClassification code 10012438Term: Dermatitis atopicSystem Organ Class: 10040785 - Skin and subcutaneous tissue disordersEUCTR2022-000434-42-SKAbbVie Deutschland GmbH & Co. KG454
尚未招募
4 期
A Phase 3b/4 Randomized, Blinded, Treat-to-Target and Dose-Flexibility Study of Upadacitinib in Adult Subjects with Moderate to Severe Atopic DermatitisAtopic dermatitisNL-OMON53671AbbVie B.V.14
进行中（未招募）
1 期
This is a study to evaluate dose-flexibility of Upadacitinib in Adult Subjects with Moderate to Severe Atopic DermatitisEUCTR2022-000434-42-NLAbbVie Deutschland GmbH & Co. KG454
招募中
4 期
A Study to Assess Treat-to-Target and Dosing Flexibility of Oral Upadacitinib Tablets in Adult Participants With Moderate to Severe Atopic DermatitisAtopic DermatitisJPRN-jRCT2011230021Yamazaki Hayato454
进行中（未招募）
不适用
A Phase 3, Randomized, Single-Blind, Controlled Trial of Topical Fibrocaps™ in Intraoperative Surgical HaemostasisIntraoperative Surgical Hemostasis (Spinal Surgery, Vascular Surgery, Hepatic resection, Soft tissue dissection)MedDRA version: 14.1Level: LLTClassification code 10053001Term: Surgical haemostasisSystem Organ Class: 100000004865EUCTR2011-006174-47-NLProFibrix Inc.672